Rifabutin-containing Triple Therapy versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial.

Jinnan ChenYixian GuoYu HuangZhaohui DingJing WangLing XiaoPing XuYaohua HanHong Lu

Published in: The Journal of infectious diseases (2023)

The rifabutin triple therapy is an alternative to classical bismuth quadruple therapy for the rescue treatment of H. pylori with lower side effects and higher compliance.

Keyphrases

helicobacter pylori
helicobacter pylori infection
randomized controlled trial
study protocol
stem cells
mesenchymal stem cells
bone marrow
cell therapy
double blind
meta analyses